Brucella Infection: A Major Public Health Concern
Editorial
Zoonotic infectious diseases are common in societies where poverty is widespread, and where people rely on animals for their livelihood, that severely hinders livestock productivity and human health worldwide, particularly in the developing world and have been historically neglected by decision makers over the decades. WHO has identified a subgroup of eight endemic or neglected zoonotic diseases- anthrax, bovine tuberculosis, brucellosis, Taenia solium cysticercosis, hydatid disease, leishmaniasis, rabies, and human African trypanosomiasis [1, 2].
The brucellosis disease is an old one and was recognized as long as 2,000 years ago, and has been known by various names, including Mediterranean fever, Malta fever, undulant fever, gastric remittent fever, Crimean fever, and Bang’s disease. In 1887, Dr. David Bruce isolated the organisms from the patients and the disease was eventually named after Dr. Bruce as brucellosis. In 1897, Dr. Bernhard Bang identified Brucella abortus, and the disease was called as Bang’s disease. Humans are accidental hosts, but brucellosis continues to be a major public health concern worldwide and is the most common zoonotic infection. The burden that the brucellosis disease places specifically on low-income countries has led the WHO to classify it as one of the world's leading neglected zoonotic disease [1, 2, 3].
Brucella bacteria are small, aerobic, highly fastidious, and intracellular Gram negative coccobacilli, and responsible for this highly contagious febrile illness called brucellosis. DNA hybridization studies reveal that the members of the genus Brucella are very closely related and probably represent variants of a single species. However, for the sake of convenience, these have been classified into six nomen species, based on various properties such as preference to animal host, CO2 requirement, H2S production, sensitivity to dyes, and agglutination by monospecific antisera, phage lysis and oxidative metabolic tests. A few are further classified into biovars [4, 5].
Brucella melitensis is the classical and the most prevalent species and is usually pathogenic for sheep and goats but other animals like cattle, camel may also be infected. Humans are also susceptible to infection with this organism. It has three biovars. Brucella abortus infects cattle, usually causing abortions. It may also infect other animals including sheep, goats, horses and dogs. It can also infect humans. It has nine biovars. Brucella suis is a natural parasite of pigs but other animals and humans may also be infected. It has five biovars. American strains of Brucella suis produce H2S, whereas Danish strains do not. Brucella canis causes abortion in dogs. Occasionally, it may produce mild fever in humans. Brucella ovis causes sexually transmitted epididymitis in rams. Brucella neotomae causes infection of wood rats. Brucella ovis and Brucella neotomae do not cause disease in humans. Three main species Brucella melitensis, Brucella abortus, and Brucella suis are pathogenic to human beings [3, 4, 5].
Because the Brucella bacteria can be aerosolized, it has been designated as a potential bioweapon [3].
Brucellosis is a chronic, life-long infection in animals such as sheep, goats, cattle, pigs, dogs etc. Organisms localize in the reproductive organs (both male and female) of host animals, and are shed in large numbers in the animal’s urine, milk, placental fluid, and other tissues discharged during delivery or spontaneous abortion. The primary manifestations of infection in animals are sterility and abortion. Transmission to humans is zoonotic, characteristically occurs as a result of either direct contact with infected animal tissues or ingestion of unpasteurized milk or milk products. Brucellosis is also an occupational hazard for people who work in the livestock sector, laboratory personnel and veterinarians. Person- to-person transmission is rare and therefore isolation of patients is not required [6, 7, 8].
Brucellae typically enter the body through cuts and abrasions on the skin, or through the GI tract. Inhalation of aerosols in the infected cowshed or slaughterhouses can also lead to disease. The brucellae spread from the initial site of infection through lymphatic channels to the regional lymph nodes, where they multiply in the macrophages of reticuloendothelial system. Then the organisms spill over into blood and disseminate to organs that are involved in the reticuloendothelial system, including the liver, spleen, kidneys, bone marrow and other lymph nodes. They have a predilection for the placenta, probably due to the presence in it of erythritol, which has a stimulating effect on brucellae in culture [4, 6].
The incubation period ranges from five days to several months, but typically lasts several weeks. The clinical presentation may be acute or insidious. The disease mimics many illnesses (e.g. leptospirosis, malaria, tularemia etc.) and presents diagnostic difficulties. Symptoms are non-specific and include malaise, fever, sweats, arthralgia/arthritis, back pains, hepatosplenomegaly, headache, anorexia, GI symptoms, and may also include depression. Their onset may be abrupt or insidious. Untreated patients may develop an undulating pattern of fever, the temperatures repeatedly rise and then fall, hence the name ‘undulant fever’ as the traditional name for brucellosis. Manifestations of brucellosis may involve any of a variety of organ systems including the GI tract, skeletal, genital, neurologic, cardiovascular and pulmonary systems. The mortality rate is low for brucellosis, about 0.4% -2%. Chronicity, recurring febrile conditions, and serious complications in pregnant women are common sequelae in brucellosis [6, 7, 8].
Brucellosis is diagnosed preliminarily by the patient’s clinical symptoms, history of exposure to likely sources of Brucella bacteria. Confirmation of the diagnosis is made by culturing Brucella bacteria from the patient. In addition, there are serological tests to detect IgM or IgG antibodies directed against LPS antigen of Brucella bacteria by a Brucella-specific agglutination test. Automated blood culture systems, ELISA and PCR have proved useful as new diagnostic methods [4, 5].
The best way to prevent brucellosis is to avoid consuming undercooked meat, unpasteurized dairy products, including milk, cheese etc. As the majority of human infections are acquired by the consumption of contaminated milk, prevention consists of checking dairy animals for brucellosis. This is achieved by the detection of infected animals, and their elimination by slaughter. Pasteurization of milk is additional safeguard. Milk ring test can be used for screening the milk for Brucella antibodies. Vaccines have been developed for use in animals. Live attenuated vaccine using Brucella abortus S19 strain for cattle and Brucella melitensis rev-1 strain for sheep and goats are available. Brucella abortus RB51 is a strain developed specifically for immunization of cattle against brucellosis to allow serological differentiation between naturally infected and vaccinated animals. A live attenuated Brucella abortus 19-BA vaccine is available for human use, but provides short-term protection [3, 9].
The gold-standard treatment regimen for adults is a combination of doxycycline for 45 days with streptomycin IM daily for 14-21 days. The WHO regimen for adults is a combination of rifampin for 6 weeks plus doxycycline for six weeks. Relapse or treatment failure may occur in 5-10% of cases. If CNS is involved, ceftriaxone is added to the regimen and treatment is prolonged for three to six months. For children, options include trimethoprim/co-trimoxazole combined with an aminoglycoside (streptomycin, gentamycin) or rifampicin [9].
As brucellosis is often misdiagnosed or overlooked, clinicians must to be aware and alert in their diagnosis of febrile diseases. It is extraordinary that even in the twenty first century we are failing to control brucellosis that severely affect rural communities in developing economies. The adoption of multidisciplinary one health approach could help to control the disease, which needs the support of global community [3, 9].
References
-
WHO (2020) Brucellosis fact sheet.
-
Dean AS, Crump L, Greter H, Schelling E, Zinsstag J (2012) Global burden of human brucellosis: a systematic review of disease frequency. PLoS Negl Trop Dis 6(10): e1865.
-
Franc KA, Krecek RC, Hasler BN, Gamboda AMA (2018) Brucellosis remains a neglected disease in the developing world: a call for interdisciplinary action. BMC Public Health 18(1): 125.
-
Reddy KR (2009) Medical Microbiology. 1st(Edn.), New Age International Publishers, New Delhi, pp: 540-543.
-
Godkar PB, Dave B, Muley L (2016) Text book of medical microbiology and parasitology. A comprehensive clinical approach with theory and practicals. 1st (Edn.), Bhalani Publishing house, Mumbai, pp: 135-138.
-
Dean AS, Crump L, Greter H, Hattendorf J, Schelling E, et al. (2012) Clinical manifestations of human brucellosis: a systematic review and meta-analysis. PLoS Negl Trop Dis 6(12): e1929.
-
Doganay M, Aygen B (2003) Human brucellosis: an overview. Int J Infect Dis 7(3): 173-182.
-
Christopher S, Umapathy BL, Ravikumar KL (2010) Brucellosis: Review on the Recent Trends in Pathogenicity and Laboratory Diagnosis. J Lab Physicians 2(2): 55-60.
-
Welburn SC, Beange I, Ducrotoy MJ, Okello AL (2015) The neglected zoonoses-the case for integrated control and advocacy. Clin Microbiol Infect 21(5): 433-443.
- Antifungal Activity of New Acetophenone Derivatives
- Interconnected Microbiomes Human Health Within an Environmental Framework
- Silkworm-Based Vaccine Production for H5N1: A One Health Approach to Pandemic Preparedness
- Microbial Diversity and Lipolytic Activity of Bacteria and Fungi from Oil-Contaminated Sites in Makurdi Metroplois
- Antibiotic Resistance Profile of Bacteria Isolated at the Central Laboratory of the National Hospital Center of Nouakchott
- Epidemiology and Sensitivity to Antibiotics of Germs Isolated from Blood Cultures in the Laboratory of the National Hospital Center of Nouakchott-Mauritania